diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)
diffuse malignant mesothelioma - biphasic
diffuse malignant mesothelioma - epithelioid
endocervical adenocarcinoma of the usual type
endometrioid endometrial adenocarcinoma (grade 1 or 2)
endometrioid endometrial adenocarcinoma (grade 3)
head and neck squamous cell carcinoma  spindle cell variant
head and neck squamous cell carcinoma basaloid type
liver - fibrolamellar hepatocellular carcinoma
lung adenocarcinoma- not otherwise specified (nos)
lung solid pattern predominant adenocarcinoma
lung squamous cell carcinoma- not otherwise specified (nos)
mucinous adenocarcinoma of endocervical type
muscle invasive urothelial carcinoma (pt2 or above)
squamous cell carcinoma  not otherwise specified
stomach  adenocarcinoma  not otherwise specified (nos)
stomach  intestinal adenocarcinoma  not otherwise specified (nos)
stomach  intestinal adenocarcinoma  tubular type
stomach  intestinal adenocarcinoma  mucinous type
stomach  intestinal adenocarcinoma  papillary type
stomach adenocarcinoma  signet ring type
thyroid papillary carcinoma - follicular (>= 99% follicular patterned)
thyroid papillary carcinoma - tall cell (>= 50% tall cell features)
uterine carcinosarcoma/ malignant mixed mullerian tumor (mmmt): nos

2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-alpha (hpph or photochlor)
calcium foliatum, fluorouracilum, oxaliplatinum, dexamethassone
rec mage 3-as + as15 acs1 / placebo vaccine

carboplatin & paclitaxel - switched to taxotere